143 related articles for article (PubMed ID: 12416746)
21. Effect of cholecystokinin on rectal motor and sensory function in patients with irritable bowel syndrome and healthy controls.
van der Schaar PJ; van Hoboken E; Ludidi S; Masclee AA
Colorectal Dis; 2013 Jan; 15(1):e29-34. PubMed ID: 23006632
[TBL] [Abstract][Full Text] [Related]
22. Alterations in rectal sensitivity and motility in childhood irritable bowel syndrome.
Van Ginkel R; Voskuijl WP; Benninga MA; Taminiau JA; Boeckxstaens GE
Gastroenterology; 2001 Jan; 120(1):31-8. PubMed ID: 11208711
[TBL] [Abstract][Full Text] [Related]
23. The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers.
Houghton LA; Lea R; Jackson N; Whorwell PJ
Gut; 2002 Apr; 50(4):471-4. PubMed ID: 11889064
[TBL] [Abstract][Full Text] [Related]
24. Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers.
Houghton LA; Foster JM; Whorwell PJ
Aliment Pharmacol Ther; 2000 Jun; 14(6):775-82. PubMed ID: 10848662
[TBL] [Abstract][Full Text] [Related]
25. Exaggerated motility of the descending colon with repetitive distention of the sigmoid colon in patients with irritable bowel syndrome.
Fukudo S; Kanazawa M; Kano M; Sagami Y; Endo Y; Utsumi A; Nomura T; Hongo M
J Gastroenterol; 2002 Nov; 37 Suppl 14():145-50. PubMed ID: 12572883
[TBL] [Abstract][Full Text] [Related]
26. Modification of visceral sensitivity and pain in irritable bowel syndrome by 5-HT3 antagonism (ondansetron).
Goldberg PA; Kamm MA; Setti-Carraro P; van der Sijp JR; Roth C
Digestion; 1996; 57(6):478-83. PubMed ID: 8913711
[TBL] [Abstract][Full Text] [Related]
27. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome.
Delvaux M; Louvel D; Mamet JP; Campos-Oriola R; Frexinos J
Aliment Pharmacol Ther; 1998 Sep; 12(9):849-55. PubMed ID: 9768527
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traits.
Camilleri M; Kolar GJ; Vazquez-Roque MI; Carlson P; Burton DD; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2013 Mar; 304(5):G553-60. PubMed ID: 23306084
[TBL] [Abstract][Full Text] [Related]
29. Motor and sensory function of the rectum in different subtypes of constipation.
Penning C; Steens J; van der Schaar PJ; Kuyvenhoven J; Delemarre JB; Lamers CB; Masclee AA
Scand J Gastroenterol; 2001 Jan; 36(1):32-8. PubMed ID: 11218237
[TBL] [Abstract][Full Text] [Related]
30. Psychological factors selectively upregulate rectal pain perception in hypersensitive patients with irritable bowel syndrome.
Grinsvall C; Törnblom H; Tack J; Van Oudenhove L; Simrén M
Neurogastroenterol Motil; 2015 Dec; 27(12):1772-82. PubMed ID: 26467837
[TBL] [Abstract][Full Text] [Related]
31. Motility disorders in the irritable bowel syndrome.
Lind CD
Gastroenterol Clin North Am; 1991 Jun; 20(2):279-95. PubMed ID: 2066153
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of rectal hypersensitivity in patients with irritable bowel syndrome and its clinical subgroups.
Rey E; Díaz-Rubio M
Rev Esp Enferm Dig; 2002 May; 94(5):247-58. PubMed ID: 12474333
[TBL] [Abstract][Full Text] [Related]
33. Do male sex hormones protect from irritable bowel syndrome?
Houghton LA; Jackson NA; Whorwell PJ; Morris J
Am J Gastroenterol; 2000 Sep; 95(9):2296-300. PubMed ID: 11007231
[TBL] [Abstract][Full Text] [Related]
34. H. pylori infection and visceral hypersensitivity in patients with irritable bowel syndrome.
Gerards C; Leodolter A; Glasbrenner B; Malfertheiner P
Dig Dis; 2001; 19(2):170-3. PubMed ID: 11549828
[TBL] [Abstract][Full Text] [Related]
35. Evolution of visceral sensitivity in patients with irritable bowel syndrome.
Poitras P; Riberdy Poitras M; Plourde V; Boivin M; Verrier P
Dig Dis Sci; 2002 Apr; 47(4):914-20. PubMed ID: 11991628
[TBL] [Abstract][Full Text] [Related]
36. Effects of chili on postprandial gastrointestinal symptoms in diarrhoea predominant irritable bowel syndrome: evidence for capsaicin-sensitive visceral nociception hypersensitivity.
Gonlachanvit S; Mahayosnond A; Kullavanijaya P
Neurogastroenterol Motil; 2009 Jan; 21(1):23-32. PubMed ID: 18647268
[TBL] [Abstract][Full Text] [Related]
37. Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism.
Zighelboim J; Talley NJ; Phillips SF; Harmsen WS; Zinsmeister AR
Dig Dis Sci; 1995 Apr; 40(4):819-27. PubMed ID: 7720476
[TBL] [Abstract][Full Text] [Related]
38. Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders.
Camilleri M; Vazquez-Roque MI; Carlson P; Burton D; Wong BS; Zinsmeister AR
Neurogastroenterol Motil; 2011 Nov; 23(11):995-9, e458. PubMed ID: 21883702
[TBL] [Abstract][Full Text] [Related]
39. Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome.
Simrén M; Törnblom H; Palsson OS; Van Oudenhove L; Whitehead WE; Tack J
Gastroenterology; 2019 Aug; 157(2):391-402.e2. PubMed ID: 31022401
[TBL] [Abstract][Full Text] [Related]
40. Pain from rectal distension in women with irritable bowel syndrome: relationship to sexual abuse.
Whitehead WE; Crowell MD; Davidoff AL; Palsson OS; Schuster MM
Dig Dis Sci; 1997 Apr; 42(4):796-804. PubMed ID: 9125652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
